- Home
- BLTE vs WRBY Comparison
BLTE vs WRBY Comparison
Compare BLTE & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- WRBY
- Stock Information
- Founded
- BLTE 2018
- WRBY 2010
- Country
- BLTE United States
- WRBY United States
- Employees
- BLTE N/A
- WRBY N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- WRBY Ophthalmic Goods
- Sector
- BLTE Health Care
- WRBY Health Care
- Exchange
- BLTE Nasdaq
- WRBY Nasdaq
- Market Cap
- BLTE 2.1B
- WRBY 2.1B
- IPO Year
- BLTE 2022
- WRBY 2021
- Fundamental
- Price
- BLTE $60.48
- WRBY $21.73
- Analyst Decision
- BLTE Strong Buy
- WRBY Buy
- Analyst Count
- BLTE 4
- WRBY 15
- Target Price
- BLTE $96.67
- WRBY $23.33
- AVG Volume (30 Days)
- BLTE 32.1K
- WRBY 2.3M
- Earning Date
- BLTE 08-08-2025
- WRBY 08-07-2025
- Dividend Yield
- BLTE N/A
- WRBY N/A
- EPS Growth
- BLTE N/A
- WRBY N/A
- EPS
- BLTE N/A
- WRBY N/A
- Revenue
- BLTE N/A
- WRBY $795,094,000.00
- Revenue This Year
- BLTE N/A
- WRBY $16.13
- Revenue Next Year
- BLTE N/A
- WRBY $13.87
- P/E Ratio
- BLTE N/A
- WRBY N/A
- Revenue Growth
- BLTE N/A
- WRBY 13.94
- 52 Week Low
- BLTE $43.70
- WRBY $12.46
- 52 Week High
- BLTE $86.53
- WRBY $28.68
- Technical
- Relative Strength Index (RSI)
- BLTE 46.26
- WRBY 58.96
- Support Level
- BLTE $58.55
- WRBY $21.23
- Resistance Level
- BLTE $62.49
- WRBY $22.43
- Average True Range (ATR)
- BLTE 1.81
- WRBY 0.81
- MACD
- BLTE -0.40
- WRBY -0.14
- Stochastic Oscillator
- BLTE 26.19
- WRBY 48.15
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.